Discover news & press releases highlighting strategic transactions and biologics development milestones !LEVA has strategically supported.
Strategic Acquisition Boosts Biopharma in Braunschweig
AveThera GmbH acquires Fraunhofer ITEM’s Braunschweig site
AveThera GmbH has successfully taken over Fraunhofer ITEM’s Braunschweig site – with strategic support from LEVA Sciences GmbH – to expand biopharmaceutical development, GMP production, and innovation capacity for faster market access of novel biologics.